Search

Home > The Bio Report > Using Drug Delivery Technology to Improve ADHD Therapies
Podcast: The Bio Report
Episode:

Using Drug Delivery Technology to Improve ADHD Therapies

Category: Business
Duration: 00:23:00
Publish Date: 2018-11-15 16:10:44
Description: People with attention-deficit/hyperactivity disorder who use stimulants to treat the condition often face afternoon crashes and require the use of booster doses. Cingulate Therapeutics is using its proprietary drug delivery technology to target this $14 billion market with timed released formulations of commonly used ADHD drugs it is developing. We spoke to Shane Schaffer, CEO of Cingulate, about ADHD, the company drug delivery technology, and its clinical path forward.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes